CANNAE HOLDINGS INC (CNNE)

US13765N1072 - Common Stock

20.15  +0.42 (+2.13%)

After market: 20.15 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CNNE. CNNE was compared to 102 industry peers in the Financial Services industry. CNNE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CNNE has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

CNNE had negative earnings in the past year.
In the past year CNNE has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CNNE reported negative net income in multiple years.
In the past 5 years CNNE always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -11.66%, CNNE is not doing good in the industry: 84.31% of the companies in the same industry are doing better.
CNNE's Return On Equity of -13.48% is on the low side compared to the rest of the industry. CNNE is outperformed by 74.51% of its industry peers.
Industry RankSector Rank
ROA -11.66%
ROE -13.48%
ROIC N/A
ROA(3y)-10.91%
ROA(5y)1.93%
ROE(3y)-12.61%
ROE(5y)2.92%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 16.68%, CNNE perfoms like the industry average, outperforming 40.20% of the companies in the same industry.
In the last couple of years the Gross Margin of CNNE has grown nicely.
The Profit Margin and Operating Margin are not available for CNNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.26%
GM growth 5Y10.11%

5

2. Health

2.1 Basic Checks

CNNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CNNE has less shares outstanding
The number of shares outstanding for CNNE has been reduced compared to 5 years ago.
The debt/assets ratio for CNNE is higher compared to a year ago.

2.2 Solvency

CNNE has an Altman-Z score of 2.94. This is not the best score and indicates that CNNE is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.94, CNNE belongs to the top of the industry, outperforming 85.29% of the companies in the same industry.
CNNE has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
CNNE has a better Debt to Equity ratio (0.04) than 77.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 2.94
ROIC/WACCN/A
WACC9.31%

2.3 Liquidity

A Current Ratio of 1.65 indicates that CNNE should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.65, CNNE is doing good in the industry, outperforming 70.59% of the companies in the same industry.
CNNE has a Quick Ratio of 1.65. This is a normal value and indicates that CNNE is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.65, CNNE is doing good in the industry, outperforming 71.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65

2

3. Growth

3.1 Past

CNNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.43%, which is quite good.
Looking at the last year, CNNE shows a very negative growth in Revenue. The Revenue has decreased by -13.91% in the last year.
Measured over the past years, CNNE shows a very negative growth in Revenue. The Revenue has been decreasing by -13.06% on average per year.
EPS 1Y (TTM)15.43%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-337.14%
Revenue 1Y (TTM)-13.91%
Revenue growth 3Y-0.9%
Revenue growth 5Y-13.06%
Revenue growth Q2Q-23.38%

3.2 Future

Based on estimates for the next years, CNNE will show a very strong growth in Earnings Per Share. The EPS will grow by 36.82% on average per year.
CNNE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.17% yearly.
EPS Next Y81.95%
EPS Next 2Y36.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.44%
Revenue Next 2Y-7.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

CNNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CNNE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as CNNE's earnings are expected to grow with 36.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.82%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CNNE!.
Industry RankSector Rank
Dividend Yield N/A

CANNAE HOLDINGS INC

NYSE:CNNE (5/3/2024, 7:04:00 PM)

After market: 20.15 0 (0%)

20.15

+0.42 (+2.13%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.46B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.66%
ROE -13.48%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 16.68%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)15.43%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y81.95%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.91%
Revenue growth 3Y-0.9%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y